Rockwell Medical (RMTI) FCF Margin (2010 - 2026)

Rockwell Medical has reported FCF Margin for 17 years, with the latest figure at 3.61% in Q1 2026.

• For the quarter ending Q1 2026, FCF Margin rose 1516.0% year-over-year to 3.61%; the trailing twelve-month figure through Mar 2026 stood at 2.49% (up 28.0% YoY), and the FY2025 full-year result was 1.79%, down 494.0% from the prior year.
• FCF Margin for Q1 2026 stood at 3.61%, down from 11.8% in the prior quarter.
• The five-year high for FCF Margin was 14.42% in Q3 2024, with the low at 61.03% in Q1 2022.
• Historically, FCF Margin has averaged 8.66% across 5 years, with a median of 5.47% in 2022.
• Annual changes were most pronounced in 2022 — FCF Margin jumped 5758 bps — and 2025, when it plunged 2434 bps.
• Rockwell Medical's FCF Margin stood at 2.03% in 2022, then surged by 81 bps to 0.39% in 2023, then jumped by 590 bps to 1.91% in 2024, then surged by 519 bps to 11.8% in 2025, then tumbled by 131 bps to 3.61% in 2026.
• The last three FCF Margin figures came in at 3.61% (Q1 2026), 11.8% (Q4 2025), and 9.91% (Q3 2025), per Business Quant data.